Product Information
XELSTRYM 18 MG/9 HR PATCH is a brand product labeled by Noven Therapeutics, LLC, priced at $16.2268 per EA under NDC 68968022003. Its NADAC has been published 107 times since Sep 18, 2024.
FDA first approved this application on Mar 22, 2022.
Strength
18 mg/1
Manufacturer
Noven Therapeutics, LLCNDC
68968022003
Classification
Brand
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
DEXTROAMPHETAMINEApproval Type
New Drug (NDA)
FDA Application
NDA215401FDA Approved
3/22/2022
On Market Since
5/15/2023
Pharmacological Classes
Price Statistics
The NADAC for XELSTRYM 18 MG/9 HR PATCH has been published 107 times since Sep 18, 2024, and over the history we have for it it has risen 5.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.2268 per EA |
|---|---|
| All-time high | $16.3076 (May 14, 2025) |
| All-time low | $15.4550 (Sep 18, 2024) |
| 52-week high | $16.2602 |
| 52-week low | $16.2163 |
| Median price | $16.2317 |
| Average price | $16.1455 |
| Largest weekly change | +5.0% (Jan 1, 2025) |
| Weeks tracked | 107 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DEXTROAMPHETAMINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Noven Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DEXTROAMPHETAMINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of XELSTRYM 18 MG/9 HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for XELSTRYM 18 MG/9 HR PATCH, manufactured by Noven Therapeutics, LLC, is $16.2268 per EA (NDC 68968022003), effective Sep 30, 2026.
How has the price of XELSTRYM 18 MG/9 HR PATCH changed over time?
Over the history we have for it, the NADAC for XELSTRYM 18 MG/9 HR PATCH has risen 5.0%. It has been tracked across 107 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for XELSTRYM 18 MG/9 HR PATCH?
Since Sep 18, 2024, the NADAC for XELSTRYM 18 MG/9 HR PATCH has ranged from a low of $15.4550 (Sep 18, 2024) to a high of $16.3076 (May 14, 2025), with a median of $16.2317 per EA.
Are there cheaper alternatives to XELSTRYM 18 MG/9 HR PATCH?
No other NADAC-published product currently shares the active ingredient and strength of XELSTRYM 18 MG/9 HR PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures XELSTRYM 18 MG/9 HR PATCH?
XELSTRYM 18 MG/9 HR PATCH (NDC 68968022003) is labeled by Noven Therapeutics, LLC, and CMS classifies it as a brand product.